Heart ultrasound to check the right heart side in sudden lung blood clots
Looks at heart ultrasound for strain on the right heart in pulmonary embolism.
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 112 people, planned
- Started
- 1 Jun 2026
- Expected to end
- 30 Nov 2026
- Type of study
- Observational
- Treatments tested
- Transthoracic Echocardiography
- Record updated
- 15 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed acute pulmonary embolism (a blood clot in the lungs). They must have had a heart ultrasound (transthoracic echocardiography) to check the right side of the heart.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Confirmed acute pulmonary embolism
- Earlier treatment
- Must have had a transthoracic echocardiography to check for right ventricular dysfunction (weak right heart chamber).
Main reasons for not taking part
- Younger than 18 years
- Incomplete clinical data
- Did not have a transthoracic echocardiography
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients aged 18 years and older
- Patients with a confirmed diagnosis of acute pulmonary embolism
- Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction
Who cannot take part
- Patients younger than 18 years
- Patients with incomplete clinical data
- Patients who did not undergo transthoracic echocardiography
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.
The group in the trial
- Patients with acute pulmonary embolism
Patients diagnosed with acute pulmonary embolism who undergo transthoracic echocardiographic assessment for evaluation of right ventricular dysfunction.
Treatment: Transthoracic Echocardiography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
- Plain-language title
- Heart ultrasound to check the right heart side in sudden lung blood clotsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 15 June 2026